Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioharvest Sciences Inc BHST


Primary Symbol: C.BHSC

BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.


CSE:BHSC - Post by User

Comment by 0checkeron Sep 04, 2021 6:22am
85 Views
Post# 33814131

RE:Cronos Group and Ginkgo Bioworks Announce Milestone

RE:Cronos Group and Ginkgo Bioworks Announce Milestone
lscfa wrote:

By achieving commercial scale production of CBG, the companies are on track to enable access to rare cannabis molecules

 

https://www.globenewswire.com/news-release/2021/08/23/2284750/0/en/Cronos-Group-and-Ginkgo-Bioworks-Announce-Achievement-of-Equity-Milestone-in-Partnership-to-Produce-Cultured-Cannabinoids.html

 





In Ginko TOO, btw.
<< Previous
Bullboard Posts
Next >>